ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

XERS Xeris Biopharma Holdings Inc

1.74
-0.02 (-1.14%)
20 Apr 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)
Total Revenue 21.43M22.07M25.31M29.73M33.14M33.2M38.01M48.32M
Operating Income -48.27M-29.07M-18.92M-18.78M-15.17M-13.28M-15.98M-4.91M
Pre Tax Income -50.79M-34.12M-26.52M-22.17M-13.27M-16.83M-20.52M-12.53M
Net Income -50.79M-33.71M-26.19M-21.83M-12.93M-16.83M-19.84M-12.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -48.27M-31.89M-23.79M-18.66M-10.76M-11.92M-15.2M-3.98M
EBITDA -47.37M-26.04M-15.85M-15.71M-12.09M-10.2M-12.88M-1.81M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 49.59M110.25M163.91M
Operating Income -115.16M-81.94M-44.01M
Pre Tax Income -122.73M-96.08M-63.5M
Net Income -122.73M-94.66M-62.26M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.983-0.695-0.451
EBIT -115.16M-85.1M-38.81M
EBITDA -113.28M-69.7M-31.68M

Your Recent History

Delayed Upgrade Clock